February 2026: New Standards in Biotechnology and Nanotechnology Advance Applied Sciences

The start of February 2026 marks a transformative milestone in the field of natural and applied sciences, with the publication of five significant international standards spanning biotechnology, nanotechnologies, and applied microbiological methods. These newly released standards introduce rigorous specifications, reporting frameworks, and process validations that are poised to drive scientific innovation and promote best practices in research, development, and industry.

For professionals working in biobanking, nanomanufacturing, analytical testing, food safety, and medical biotechnology, these changes are critical. The standards detailed here set a new benchmark for quality management, reproducibility, and global harmonization—equipping organizations to meet heightened regulatory expectations and technological challenges.

Overview / Introduction

The natural and applied sciences sector is rapidly evolving through advances in biotechnology, nanotechnology, analytical chemistry, and microbiology. Maintaining comparability, reliability, and safety in this landscape depends upon robust, internationally agreed standards that facilitate science-based decision-making and global collaboration.

This article guides professionals through five of the most significant international standards published in February 2026 for this field. You’ll discover:

• The scope and key requirements of each new standard
• Practical implications for biobanking, laboratory testing, nanomaterial production, food chain safety, and therapeutic development
• How these specifications promote quality assurance, compliance, and innovation across the research and industrial ecosystem

Detailed Standards Coverage

ISO 20012:2026 – Biobanking Requirements for Human Natural Killer Cells Derived from Pluripotent Stem Cells

Biotechnology — Biobanking — Requirements for human natural killer cells derived from pluripotent stem cells

This international standard lays out comprehensive requirements for biobanking of human natural killer (NK) cells produced from human pluripotent stem cells (hPSCs). Its provisions encompass differentiation, culture, characterization, quality control, storage, thawing, and transportation processes, ensuring NK cell samples for research and development (not clinical therapy) are of consistent, high quality.

Organizations engaged in stem cell research, academic centers, and public/private biobanks will find detailed protocols on:

• Legal and ethical compliance
• Personnel qualification, facility, and equipment standards
• Documentation and data management practices
• Step-by-step process for generating hPSC-derived NK cells, including cell identification and infectious agent testing
• Cell characterization methods: viability, morphology, purity, population doubling time, immunophenotyping, microbiological purity, and cellular function assessments
• Quality control, storage, thawing, and disposal guidance
• In-depth transport requirements for both frozen and live cell shipments

Notably, this standard references other foundational documents (like ISO 24603) for upstream pluripotent stem cell procurement and conditioning. It excludes requirements for therapeutic/in vivo applications but sets a robust quality base for R&D.

Key highlights:

• Detailed quality control procedures for NK cell processing and storage
• Clear protocols for documentation, traceability, and user information
• Applicable to all research-focused biobanks handling hPSC-NK cells

Access the full standard:View ISO 20012:2026 on iTeh Standards

IEC TS 62565-3-6:2026 – Specification Templates for Graphene Oxide Powders and Dispersions

Nanomanufacturing - Product specification - Part 3-6: Graphene-related products - Blank detail specification: graphene oxide in powders and dispersions

This technical specification delivers a harmonized template for detailing the properties of graphene oxide—used in coatings, electronic components, drug carriers, and advanced manufacturing—whether in powder form or aqueous dispersions. The standard identifies key control characteristics (KCCs) crucial for consistent industrial uptake, such as graphite structure, water/solid content, density, UV-vis-NIR absorption, and quality metrics dependent on synthesis pathways.

The IEC document introduces standardized reporting formats, leaves certain numeric product values open for supplier-customer agreement, and provides guidance on measurement methods with references to advanced international standards in the IEC 62607 series. It also outlines adaptable requirements for non-aqueous dispersions, emphasizing flexibility and transparency in procurement and quality assurance contracts.

Target users: Nanomaterials manufacturers, procurement specialists, R&D labs, and QC teams involved in specifying or purchasing graphene oxide-based products.

Key highlights:

• Blank detail specification template for structured procurement
• Inventory of measurable KCCs relevant to industrial applications
• Measurement and reporting guidelines for powders and dispersions

Access the full standard:View IEC TS 62565-3-6:2026 on iTeh Standards

EN ISO 21362:2026 – Analytical Methods for Nano-Objects Using Field-Flow Fractionation

Nanotechnologies - Analysis of nano-objects using asymmetrical flow and centrifugal field-flow fractionation (ISO 21362:2026)

This document provides laboratories and analytical chemists with theory, best practices, and clear reporting requirements for the use of asymmetrical flow and centrifugal field-flow fractionation (AF4 and CF3) in characterizing nano-objects. Such techniques are widely used to measure size distributions, aggregation states, and composition of nanoparticles in aqueous media—critical for nanomaterials development, risk assessment, and quality control.

The standard:

• Describes the operation principles for both AF4 and centrifugal FFF
• Specifies minimal and optional reporting elements for method validation and inter-lab comparability
• Details method development steps, including sample preparation, carrier and mobile phase specifications, channel and membrane selection, flow conditions, and validation of performance metrics (e.g., selectivity, recovery, resolution)
• Provides practical calibration and maintenance guidelines for fractional systems

Applicable to reference laboratories, nanotechnology R&D teams, quality assurance units, and regulatory agencies requiring reproducible, rigorously defined measurement systems in nanoscience and engineering settings.

Key highlights:

• Standardizes reporting for size-based separation and characterization of nano-objects
• Supports validation, calibration, and cross-laboratory comparability
• Addresses both asymmetrical flow (AF4) and centrifugal (CF3) fractionation techniques

Access the full standard:View EN ISO 21362:2026 on iTeh Standards

ISO 23691:2026 – Determination and Use of Cardinal Values in Food Chain Microbiology

Microbiology of the food chain — Determination and use of cardinal values

ISO 23691:2026 defines a rigorous methodology for determining the cardinal values (growth parameters) of bacteria and yeast strains—data essential for conducting predictive microbiological modeling in food safety and quality assurance. The standard focuses on predicting microbial growth as influenced by temperature, pH, water activity (aw), and chemical inhibitors, using well-validated experimental and statistical steps.

The standard clarifies:

• Experimental design for strain selection, broth preparation, and test conditions
• Stepwise determination of maximum specific growth rates under varied environmental parameters
• Application of secondary models to fit and interpret the collected data, then derive cardinal values
• Correction and validation methods for transferring lab-obtained cardinal values to real food matrices
• Integration of results with challenge test data for robust food chain simulations

This comprehensive approach is vital for food processors, testing labs, regulatory agencies, and R&D teams concerned with hazard analysis, shelf-life prediction, and HACCP compliance.

Key highlights:

• Standardizes experiments for cardinal values and durability assessment
• Includes both broth-based and matrix-corrected protocols
• Supports compliance with food chain predictive microbiology frameworks and regulatory standards

Access the full standard:View ISO 23691:2026 on iTeh Standards

ISO/TS 20853:2026 – General Requirements for Therapeutic Bacteriophage Preparation

Biotechnology — Bioprocessing — General requirements for bacteriophage preparation for therapeutic use

With the renewed focus on phage therapy as a tool against antimicrobial resistance, ISO/TS 20853:2026 addresses the end-to-end requirements for preparing, isolating, and quality-controlling bacteriophage suspensions intended for therapeutic applications. The standard lays out a robust workflow comprising environmental sampling, host preparation, phage enrichment, isolation, amplification, purification, storage, genomic sequencing, and bioinformatics screening.

It specifies minimum titers for storage and use, cleaning procedures (e.g., endotoxin and exotoxin removal), sterility and residual bacterial DNA criteria, quality assurance on protein contaminants, and best-practice storage for both working and master phage stocks.

Applicable to biotech companies, clinical microbiology labs, and therapeutics developers, this specification helps align practice to modern drug approval, GMP manufacturing, and safe clinical use.

Key highlights:

• Defines a robust workflow for phage isolation, amplification, and storage
• Mandatory tests for endotoxin and exotoxin removal, genetic screening, pH, and purity
• Strong focus on documentation and batch traceability for clinical applications

Access the full standard:View ISO/TS 20853:2026 on iTeh Standards

Industry Impact & Compliance

The publication of these February 2026 standards signals a tightening of best practices and greater harmonization in the applied sciences:

• For biobanking, biotechnology, and nanotechnology organizations, these requirements bolster confidence in data robustness, sample traceability, and product quality, enabling entry into global research or commercial collaborations.
• Food industry and contract testing labs benefit from reference methodologies that satisfy regulatory audits and underpin hazard analyses for food safety management.
• Manufacturers and suppliers of advanced materials such as graphene oxide gain a shared template for procurement, quality contracts, and technical reporting.

Industry professionals will need to review existing workflows, train staff on new testing or reporting norms, and ensure documentation aligns with the latest requirements. Transition timelines will depend on individual regulatory markets, but proactive adoption provides reputational and operational advantages.

Benefits include:

• Reduced risk of non-compliance during audits
• Access to international R&D and supply chains
• Streamlined procurement, process validation, and quality assurance
• Increased market access and customer trust through demonstrable best practices

Risks of non-compliance may involve regulatory penalties, sample rejection, or loss of accreditation—especially for entities in pharmaceutical, medical, food, or advanced materials markets.

Technical Insights

Across these diverse standards, several common technical threads emerge:

• Emphasis on documentation and traceability: Nearly all the standards require detailed records, sample tracking, and clear reporting for process reproducibility, auditability, and user safety.
• Measurement standardization: Harmonized testing protocols, calibration routines, and result reporting assure comparability across laboratories and countries.
• Quality control and validation: Robust internal quality checks, control sample inclusion, and adherence to validated methods are foundational.
• Best practices for storage and transport: Clear protocols for cryopreservation, transportation at controlled temperatures, and periodic verification of sample viability and quality.
• Cross-references to related standards: Each standard builds on previous ISO or IEC documents, ensuring the ecosystem of requirements is mutually supportive and up-to-date.

Implementation best practices:

1. Conduct a gap analysis against the new standards
2. Update laboratory or production SOPs accordingly
3. Train technical staff in the new methods, QC procedures, and documentation requirements
4. Engage with suppliers using the new blank detail procurement templates and checklists
5. Plan for certification or third-party audits as part of compliance demonstration

Testing and certification—especially for nanomaterials or products entering regulated markets—should leverage referenced international standards, harmonized reporting fields, and performance qualification steps for new analytical instruments or production processes.

Conclusion / Next Steps

The international standards published for February 2026 in biotechnology, nanomaterial characterization, food chain microbiology, and therapeutic phage preparation represent both a challenge and an opportunity for organizations operating at the forefront of applied sciences. Regulatory agencies, R&D labs, and manufacturers are encouraged to:

• Review and adapt their internal processes using the full documents linked above
• Communicate with supply chain partners to ensure mutual understanding of the new requirements
• Stay updated with iTeh Standards for future parts in this series and subsequent industry developments

By timely adopting and fully implementing these standards, organizations can ensure compliance, innovation readiness, and competitive leadership in the global landscape of the natural and applied sciences.